BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines.
What BALAXI files
- Others58
- Important17
- Board Meeting12
- PPTs8
- Insider Trade3
- Results3
The company clarified errors in its financial results, revising XBRL filings. Standalone total expenses were adjusted by 0.20 Cr. Crucially, consolidated other comprehensive income for the latest quarter and fiscal year was corrected from negative to positive, significantly impacting total comprehensive income.
Balaxi Pharmaceuticals has announced a board meeting on May 30, 2025, approving consolidated financial results for FY25. 1) Revenue Performance: Consolidated revenue from operations declined 16% YoY to Rs. 202.56 Cr, primarily due to lower volumes in its specialized wholesale segment. 2) Profitability and EPS: Net profit surged to Rs....
Balaxi Pharmaceuticals Limited has announced a board meeting to review the financial results for the quarter and nine months ended December 31, 2024. The standalone revenue from operations decreased to ₹11.16 crore compared to ₹12.70 crore in the previous year, while total income rose slightly to ₹14.07 crore. Net profit...